Dimensional Fund Advisors LP Pliant Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 456,166 shares of PLRX stock, worth $5.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

456,166

Previous 305,322 49.4%

Holding current value

$5.67 Million

Previous $3.28 Million 55.79%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$10.52 - $14.35 $1.59 Million - $2.16 Million	150,844 Added 49.4%	456,166 $5.11 Million
Q2 2024 Aug 09, 2024	BUY	$10.58 - $15.61 $54,508 - $80,422	5,152 Added 1.72%	305,322 $3.28 Million
Q1 2024 May 10, 2024	BUY	$14.14 - $19.59 $2.07 Million - $2.86 Million	146,098 Added 94.82%	300,170 $4.47 Million
Q4 2023 Feb 07, 2024	BUY	$12.85 - $19.15 $1.25 Million - $1.87 Million	97,420 Added 171.96%	154,072 $2.79 Million
Q3 2023 Nov 09, 2023	SELL	$14.58 - $20.15 $1.08 Million - $1.49 Million	-74,059 Reduced 56.66%	56,652 $982,000
Q2 2023 Aug 09, 2023	SELL	$18.12 - $30.56 $1.48 Million - $2.5 Million	-81,745 Reduced 38.48%	130,711 $2.37 Million
Q1 2023 May 12, 2023	BUY	$18.73 - $36.26 $1.28 Million - $2.48 Million	68,489 Added 47.57%	212,456 $5.65 Million
Q4 2022 Feb 09, 2023	BUY	$17.0 - $25.43 $2.11 Million - $3.16 Million	124,106 Added 624.87%	143,967 $2.78 Million
Q3 2022 Nov 10, 2022	BUY	$7.67 - $24.23 $39,531 - $124,881	5,154 Added 35.04%	19,861 $415,000
Q2 2022 Aug 12, 2022	BUY	$4.11 - $8.75 $5,030 - $10,710	1,224 Added 9.08%	14,707 $118,000
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $94,515 - $190,110	13,483 New	13,483 $95,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $605M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Pliant Therapeutics, Inc. Transaction History